Safety & Efficacy of Dalbavcancin Versus Vancomycin in the Treatment of Catheter-Related Bloodstream Infections with Suspected or Confirmed Gram-Positive Bacterial Pathogens

Grants and Contracts Details

StatusFinished
Effective start/end date7/5/026/30/04

Funding

  • Versicor Inc: $3,000.00